Department of Respiratory Medicine, Zunyi Honghuagang District People's Hospital, 185 Wanli Road, HongHuagang District, 563000, Guizhou, China.
Department of Respiratory Medicine, the Third Affiliated Hospital of Zunyi Medical University, 98 Fenghuang Road, Huichuan District, 563000, Guizhou, China.
Wien Klin Wochenschr. 2022 Jan;134(1-2):24-38. doi: 10.1007/s00508-021-01971-3. Epub 2021 Dec 3.
The relationship between acute respiratory distress syndrome (ARDS)/acute lung injury (ALI) and levels of certain inflammatory factors remains controversial. The purpose of this meta-analysis was to summarize the available studies evaluating the association between levels of inflammatory factors and ARDS/ALI incidence.
We searched the PubMed, EmBase, and Cochrane databases for studies published up to July 2017. For each inflammatory factor, a random effects model was employed to pool results from different studies.
We identified 63 studies that included 6243 patients in our meta-analysis. Overall, the results indicated that the levels of angiopoietin (ANG)-2 (standard mean difference, SMD: 1.34; P < 0.001), interleukin (IL)-1β (SMD: 0.92; P = 0.012), IL‑6 (SMD: 0.66; P = 0.005), and tumor necrosis factor (TNF)-α (SMD: 0.98; P = 0.001) were significantly higher in patients with ARDS/ALI than in unaffected individuals. No significant differences were observed between patients with ARDS/ALI and unaffected individuals in terms of the levels of IL‑8 (SMD: 0.61; P = 0.159), IL-10 (SMD: 1.10; P = 0.231), and plasminogen activator inhibitor (PAI)-1 (SMD: 0.70; P = 0.060).
ARDS/ALI is associated with a significantly elevated levels of ANG‑2, IL-1β, IL‑6, and TNF‑α, but not with IL‑8, IL-10, and PAI‑1 levels.
急性呼吸窘迫综合征(ARDS)/急性肺损伤(ALI)与某些炎症因子水平之间的关系仍存在争议。本荟萃分析的目的是总结评估炎症因子水平与 ARDS/ALI 发生率之间关系的现有研究。
我们检索了截至 2017 年 7 月发表的 PubMed、EmBase 和 Cochrane 数据库中的研究。对于每个炎症因子,采用随机效应模型汇总来自不同研究的结果。
我们确定了 63 项研究,其中有 6243 名患者纳入我们的荟萃分析。总的来说,结果表明,血管生成素(ANG)-2(标准化均数差,SMD:1.34;P<0.001)、白细胞介素(IL)-1β(SMD:0.92;P=0.012)、IL-6(SMD:0.66;P=0.005)和肿瘤坏死因子(TNF)-α(SMD:0.98;P=0.001)的水平在 ARDS/ALI 患者中明显高于无影响的个体。ARDS/ALI 患者与无影响的个体之间在白细胞介素(IL)-8(SMD:0.61;P=0.159)、IL-10(SMD:1.10;P=0.231)和纤溶酶原激活物抑制剂(PAI)-1(SMD:0.70;P=0.060)的水平方面无显著差异。
ARDS/ALI 与 ANG-2、IL-1β、IL-6 和 TNF-α水平显著升高相关,但与 IL-8、IL-10 和 PAI-1 水平无关。